Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

January 31, 2002

Study Completion Date

August 31, 2006

Conditions

Intraocular MelanomaMelanoma (Skin)

Interventions

BIOLOGICAL

gp100 antigen

BIOLOGICAL

incomplete Freund's adjuvant

BIOLOGICAL

ipilimumab

Trial Locations (1)

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00032045 - Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma | Biotech Hunter | Biotech Hunter